VeriMom¿Es crataegus pinnatifida fruit extract seguro durante el embarazo?
No harmonised CLP reproductive classification for Crataegus pinnatifida fruit extract (no ECHA Annex VI entry). No CIR or SCCS safety assessment flagging reproductive toxicity. PubMed literature on C. pinnatifida reports antioxidant/cardiovascular pharmacology but no consistent evidence of teratogenicity or human reproductive hazard from topical use. Typical topical plant extracts have low but measurable dermal exposure in cosmetics, so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard studies identified), PubChem/CosIng entries (ingredient identity and cosmetic use).
Related ingredients
Frequently asked questions
- ¿Es crataegus pinnatifida fruit extract seguro durante el embarazo?
- No harmonised CLP reproductive classification for Crataegus pinnatifida fruit extract (no ECHA Annex VI entry). No CIR or SCCS safety assessment flagging reproductive toxicity. PubMed literature on C. pinnatifida reports antioxidant/cardiovascular pharmacology but no consistent evidence of teratogenicity or human reproductive hazard from topical use. Typical topical plant extracts have low but measurable dermal exposure in cosmetics, so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard studies identified), PubChem/CosIng entries (ingredient identity and cosmetic use).
- ¿Es crataegus pinnatifida fruit extract seguro durante la lactancia?
- No evidence of reproductive or lactation-specific toxicity or transfer in humans for C. pinnatifida fruit extract in the referenced sources. Mechanistic data for placental or breast‑milk transfer are not available. Given low but measurable dermal exposure from cosmetics, exposure scored as low (1). Sources: PubMed (no breastfeeding transfer data), CosIng/PubChem (use and composition information).
- ¿Es crataegus pinnatifida fruit extract seguro para la piel del bebé?
- No infant-specific safety signals or reproductive/dermal toxicity data identified. Mechanistic concerns not identified. Because infant skin has higher absorption (immature barrier and higher surface-area-to-weight), exposure is increased by +1 vs adult (adult e=1 → infant e=2). Sources: general dermal exposure principles, CosIng/PubChem for ingredient use, PubMed (no infant-specific hazard data).
- ¿Cómo puntúa VeriMom a crataegus pinnatifida fruit extract?
- VeriMom puntúa crataegus pinnatifida fruit extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a crataegus pinnatifida fruit extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a crataegus pinnatifida fruit extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.